Search

Your search keyword '"Thompson, Jeffrey C."' showing total 191 results
Start Over Author "Thompson, Jeffrey C."
191 results on '"Thompson, Jeffrey C."'

2. Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression

Author

Friedes, Cole, Yegya-Raman, Nikhil, Zhang, Siqi, Iocolano, Michelle, Cohen, Roger B., Aggarwal, Charu, Thompson, Jeffrey C., Marmarelis, Melina E., Levin, William P., Cengel, Keith A., Ciunci, Christine A., Singh, Aditi P., D'Avella, Christopher, Davis, Christiana W., Langer, Corey J., and Feigenberg, Steven J.

Published
2024
Full Text
View/download PDF

3. Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy

Author

Singh, Apurva, Horng, Hannah, Roshkovan, Leonid, Weeks, Joanna K., Hershman, Michelle, Noël, Peter, Luna, José Marcio, Cohen, Eric A., Pantalone, Lauren, Shinohara, Russell T., Bauml, Joshua M., Thompson, Jeffrey C., Aggarwal, Charu, Carpenter, Erica L., Katz, Sharyn I., and Kontos, Despina

Published
2022
Full Text
View/download PDF

4. Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line Patients.

Author

Thompson, Jeffrey C., Tilsed, Caitlin, Davis, Christiana, Gupta, Aasha, Melidosian, Bihui, Sun, Chifei, Kallen, Michael E., Timmers, Cynthia, Langer, Corey J., and Albelda, Steven M.

Abstract

Simple Summary: Although the high mutation burden in small-cell lung cancer (SCLC) suggests that it should be responsive to immune checkpoint blockade (ICB), relatively few patients have shown durable clinical benefit (DCB). To identify biomarkers of responses, biopsies from 35 patients treated with ICB (21 first-line and 14 second-line) were subjected to transcriptomic analysis and gene signatures were studied. Patients with DCB were compared to those with no clinical benefit (NCB). The response to ICB in the second-line, but not the first-line, setting was associated with gene signatures of inflammation, antigen presentation, interferon responses, and increased CD8 T cells. Our data suggest that responses to ICB in the second-line setting can be predicted by the baseline inflammatory state of the tumor; however, this strong association with inflammation was not observed in the first-line setting, likely because chemotherapy alters the immune milieu allowing a response to ICB. Although immune checkpoint blockade (ICB) is currently approved for the treatment of extensive-stage small-cell lung cancer (SCLC) in combination with chemotherapy, relatively few patients have demonstrated durable clinical benefit (DCB) to these therapies. Biomarkers predicting responses are needed. Biopsies from 35 SCLC patients treated with ICB were subjected to transcriptomic analysis; gene signatures were assessed for associations with responses. Twenty-one patients were treated with ICB in the first-line setting in combination with platinum-based chemotherapy; fourteen patients were treated in the second-line setting with ICB alone. DCB after ICB in SCLC in the second-line setting (3 of 14 patients) was associated with statistically higher transcriptomic levels of genes associated with inflammation (p = 0.003), antigen presentation machinery (p = 0.03), interferon responses (p < 0.05), and increased CD8 T cells (p = 0.02). In contrast, these gene signatures were not significantly different in the first-line setting. Our data suggest that responses to ICB in SCLC in the second-line setting can be predicted by the baseline inflammatory state of the tumor; however, this strong association with inflammation was not seen in the first-line setting. We postulate that chemotherapy alters the immune milieu allowing a response to ICB. Other biomarkers will be needed to predict responses in first-line therapy patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

5. University of Pennsylvania Telehealth Research Center of Excellence.

Author

Wainwright, Jocelyn V, Aggarwal, Charu, Beucker, Sarah, Dougherty, David W, Gabriel, Peter E, Jacobs, Linda A, Kalman, Jillian, Linn, Kristin A, Martella, Anthony O, Mehta, Shivan J, Rhodes, Corinne M, Roy, Megan, Schapira, Marilyn M, Shulman, Lawrence N, Steltz, Jennifer, Shields, Alisa J Stephens, Tan, Andy S L, Thompson, Jeffrey C, Toneff, Hannah, and Wender, Richard C

Published
2024
Full Text
View/download PDF

7. Red Blood Cells Function as Reservoirs of Tumor DNA

Author

Thompson, Jeffrey C., primary, Li, Sue, additional, Jose, Joshua S., additional, Predina, Jarrod, additional, Gupta, Aasha, additional, Eruslanov, Evgeniy, additional, Singhal, Sunil, additional, Albelda, Steven M., additional, and Mangalmurti, Nilam S., additional

Published
2024
Full Text
View/download PDF

8. Brief Report: Impact of reflex testing on tissue-based molecular genotyping in patients with advanced non-squamous non-small cell lung cancer

Author

Marmarelis, Melina E., primary, Scholes, Dylan G., additional, McGrath, Cindy M., additional, Priore, Salvatore F., additional, Roth, Jacquelyn J., additional, Feldman, Michael, additional, Morrissette, Jennifer J.D., additional, Litzky, Leslie, additional, Deshpande, Charu, additional, Thompson, Jeffrey C., additional, Doucette, Abigail, additional, Gabriel, Peter E., additional, Sun, Lova, additional, Singh, Aditi P., additional, Cohen, Roger B., additional, Langer, Corey J., additional, Carpenter, Erica L., additional, and Aggarwal, Charu, additional

Published
2024
Full Text
View/download PDF

9. Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

Author

Vega, Diana Merino, Nishimura, Katherine K., Zariffa, Névine, Thompson, Jeffrey C., Hoering, Antje, Cilento, Vanessa, Rosenthal, Adam, Anagnostou, Valsamo, Baden, Jonathan, Beaver, Julia A., Chaudhuri, Aadel A., Chudova, Darya, Fine, Alexander D., Fiore, Joseph, Hodge, Rachel, Hodgson, Darren, Hunkapiller, Nathan, Klass, Daniel M., Kobie, Julie, Peña, Carol, Pennello, Gene, Peterman, Neil, Philip, Reena, Quinn, Katie J., Raben, David, Rosner, Gary L., Sausen, Mark, Tezcan, Ayse, Xia, Qi, Yi, Jing, Young, Amanda G., Stewart, Mark D., Carpenter, Erica L., Aggarwal, Charu, and Allen, Jeff

Published
2022
Full Text
View/download PDF

12. Patterns of Failure in Metastatic NSCLC Treated with First Line Pembrolizumab and Use of Local Therapy in Patients with Oligoprogression

Author

Friedes, Cole, primary, Yegya-Raman, Nikhil, additional, Zhang, Siqi, additional, Iocolano, Michelle, additional, Cohen, Roger B., additional, Aggarwal, Charu, additional, Thompson, Jeffrey C., additional, Marmarelis, Melina E., additional, Levin, William P., additional, Cengel, Keith A., additional, Ciunci, Christine A., additional, Singh, Aditi P., additional, D'Avella, Christopher, additional, Davis, Christiana W., additional, Langer, Corey J., additional, and Feigenberg, Steven J., additional

Published
2023
Full Text
View/download PDF

13. Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer

Author

Aggarwal, Charu, primary, Marmarelis, Melina E., additional, Hwang, Wei-Ting, additional, Scholes, Dylan G., additional, McWilliams, Tara L., additional, Singh, Aditi P., additional, Sun, Lova, additional, Kosteva, John, additional, Costello, Michael R., additional, Cohen, Roger B., additional, Langer, Corey J., additional, Doucette, Abigail, additional, Gabriel, Peter N., additional, Shulman, Lawrence N., additional, Rendle, Katharine A., additional, Thompson, Jeffrey C., additional, Bekelman, Justin E., additional, and Carpenter, Erica L., additional

Published
2023
Full Text
View/download PDF

14. Hepatocytes direct the formation of a pro-metastatic niche in the liver

Author

Lee, Jae W., Stone, Meredith L., Porrett, Paige M., Thomas, Stacy K., Komar, Chad A., Li, Joey H., Delman, Devora, Graham, Kathleen, Gladney, Whitney L., Hua, Xia, Black, Taylor A., Chien, Austin L., Majmundar, Krishna S., Thompson, Jeffrey C., Yee, Stephanie S., O’Hara, Mark H., Aggarwal, Charu, Xin, Dong, Shaked, Abraham, Gao, Mingming, Liu, Dexi, Borad, Mitesh J., Ramanathan, Ramesh K., Carpenter, Erica L., Ji, Ailing, de Beer, Maria C., de Beer, Frederick C., Webb, Nancy R., and Beatty, Gregory L.

Published
2019
Full Text
View/download PDF

15. Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy

Author

Thompson, Jeffrey C., Carpenter, Erica L., Silva, Benjamin A., Rosenstein, Jamie, Chien, Austin L., Quinn, Katie, Espenschied, Carin R., Mak, Allysia, Kiedrowski, Lesli A., Lefterova, Martina, Nagy, Rebecca J., Katz, Sharyn I., Yee, Stephanie S., Black, Taylor A., Singh, Aditi P., Ciunci, Christine A., Bauml, Joshua M., Cohen, Roger B., Langer, Corey J., and Aggarwal, Charu

Published
2021
Full Text
View/download PDF

18. A radiomics-based model for the outcome prediction in COVID-19 positive patients through deep learning with both longitudinal chest x-ray and chest computed tomography images

Author

Zou, Chunrui, primary, Mankowski, Walter, additional, Pantalone, Lauren, additional, Setia Verma, Shefali, additional, Mortani Barbosa, Eduardo J., additional, Cook, Tessa S., additional, Noel, Peter B., additional, Carpenter, Erica L., additional, Thompson, Jeffrey C., additional, Shinohara, Russell T., additional, Katz, Sharyn I., additional, and Kontos, Despina, additional

Published
2023
Full Text
View/download PDF

19. Supplementary Figures from Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non–Small Cell Lung Cancer

Author

O'Brien, Shaun M., primary, Klampatsa, Astero, primary, Thompson, Jeffrey C., primary, Martinez, Marina C., primary, Hwang, Wei-Ting, primary, Rao, Abishek S., primary, Standalick, Jason E., primary, Kim, Soyeon, primary, Cantu, Edward, primary, Litzky, Leslie A., primary, Singhal, Sunil, primary, Eruslanov, Evgeniy B., primary, Moon, Edmund K., primary, and Albelda, Steven M., primary

Published
2023
Full Text
View/download PDF

20. Data from Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non–Small Cell Lung Cancer

Author

O'Brien, Shaun M., primary, Klampatsa, Astero, primary, Thompson, Jeffrey C., primary, Martinez, Marina C., primary, Hwang, Wei-Ting, primary, Rao, Abishek S., primary, Standalick, Jason E., primary, Kim, Soyeon, primary, Cantu, Edward, primary, Litzky, Leslie A., primary, Singhal, Sunil, primary, Eruslanov, Evgeniy B., primary, Moon, Edmund K., primary, and Albelda, Steven M., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Methods from Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non–Small Cell Lung Cancer

Author

O'Brien, Shaun M., primary, Klampatsa, Astero, primary, Thompson, Jeffrey C., primary, Martinez, Marina C., primary, Hwang, Wei-Ting, primary, Rao, Abishek S., primary, Standalick, Jason E., primary, Kim, Soyeon, primary, Cantu, Edward, primary, Litzky, Leslie A., primary, Singhal, Sunil, primary, Eruslanov, Evgeniy B., primary, Moon, Edmund K., primary, and Albelda, Steven M., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Table 1 from Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non–Small Cell Lung Cancer

Author

O'Brien, Shaun M., primary, Klampatsa, Astero, primary, Thompson, Jeffrey C., primary, Martinez, Marina C., primary, Hwang, Wei-Ting, primary, Rao, Abishek S., primary, Standalick, Jason E., primary, Kim, Soyeon, primary, Cantu, Edward, primary, Litzky, Leslie A., primary, Singhal, Sunil, primary, Eruslanov, Evgeniy B., primary, Moon, Edmund K., primary, and Albelda, Steven M., primary

Published
2023
Full Text
View/download PDF

23. Supplemental Table 2 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Author

Thompson, Jeffrey C., primary, Yee, Stephanie S., primary, Troxel, Andrea B., primary, Savitch, Samantha L., primary, Fan, Ryan, primary, Balli, David, primary, Lieberman, David B., primary, Morrissette, Jennifer D., primary, Evans, Tracey L., primary, Bauml, Joshua, primary, Aggarwal, Charu, primary, Kosteva, John A., primary, Alley, Evan, primary, Ciunci, Christine, primary, Cohen, Roger B., primary, Bagley, Stephen, primary, Stonehouse-Lee, Susan, primary, Sherry, Victoria E., primary, Gilbert, Elizabeth, primary, Langer, Corey, primary, Vachani, Anil, primary, and Carpenter, Erica L., primary

Published
2023
Full Text
View/download PDF

24. Supplemental Table 3 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Author

Thompson, Jeffrey C., primary, Yee, Stephanie S., primary, Troxel, Andrea B., primary, Savitch, Samantha L., primary, Fan, Ryan, primary, Balli, David, primary, Lieberman, David B., primary, Morrissette, Jennifer D., primary, Evans, Tracey L., primary, Bauml, Joshua, primary, Aggarwal, Charu, primary, Kosteva, John A., primary, Alley, Evan, primary, Ciunci, Christine, primary, Cohen, Roger B., primary, Bagley, Stephen, primary, Stonehouse-Lee, Susan, primary, Sherry, Victoria E., primary, Gilbert, Elizabeth, primary, Langer, Corey, primary, Vachani, Anil, primary, and Carpenter, Erica L., primary

Published
2023
Full Text
View/download PDF

25. Supplemental Table 6 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Author

Thompson, Jeffrey C., primary, Yee, Stephanie S., primary, Troxel, Andrea B., primary, Savitch, Samantha L., primary, Fan, Ryan, primary, Balli, David, primary, Lieberman, David B., primary, Morrissette, Jennifer D., primary, Evans, Tracey L., primary, Bauml, Joshua, primary, Aggarwal, Charu, primary, Kosteva, John A., primary, Alley, Evan, primary, Ciunci, Christine, primary, Cohen, Roger B., primary, Bagley, Stephen, primary, Stonehouse-Lee, Susan, primary, Sherry, Victoria E., primary, Gilbert, Elizabeth, primary, Langer, Corey, primary, Vachani, Anil, primary, and Carpenter, Erica L., primary

Published
2023
Full Text
View/download PDF

26. Supplemental Table 1 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Author

Thompson, Jeffrey C., primary, Yee, Stephanie S., primary, Troxel, Andrea B., primary, Savitch, Samantha L., primary, Fan, Ryan, primary, Balli, David, primary, Lieberman, David B., primary, Morrissette, Jennifer D., primary, Evans, Tracey L., primary, Bauml, Joshua, primary, Aggarwal, Charu, primary, Kosteva, John A., primary, Alley, Evan, primary, Ciunci, Christine, primary, Cohen, Roger B., primary, Bagley, Stephen, primary, Stonehouse-Lee, Susan, primary, Sherry, Victoria E., primary, Gilbert, Elizabeth, primary, Langer, Corey, primary, Vachani, Anil, primary, and Carpenter, Erica L., primary

Published
2023
Full Text
View/download PDF

27. Data from Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer

Author

Aggarwal, Charu, primary, Thompson, Jeffrey C., primary, Chien, Austin L., primary, Quinn, Katie J., primary, Hwang, Wei-Ting, primary, Black, Taylor A., primary, Yee, Stephanie S., primary, Christensen, Theresa E., primary, LaRiviere, Michael J., primary, Silva, Benjamin A., primary, Banks, Kimberly C., primary, Nagy, Rebecca J., primary, Helman, Elena, primary, Berman, Abigail T., primary, Ciunci, Christine A., primary, Singh, Aditi P., primary, Wasser, Jeffrey S., primary, Bauml, Joshua M., primary, Langer, Corey J., primary, Cohen, Roger B., primary, and Carpenter, Erica L., primary

Published
2023
Full Text
View/download PDF

28. Supplemental Figure 2 from Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer

Author

Aggarwal, Charu, primary, Thompson, Jeffrey C., primary, Chien, Austin L., primary, Quinn, Katie J., primary, Hwang, Wei-Ting, primary, Black, Taylor A., primary, Yee, Stephanie S., primary, Christensen, Theresa E., primary, LaRiviere, Michael J., primary, Silva, Benjamin A., primary, Banks, Kimberly C., primary, Nagy, Rebecca J., primary, Helman, Elena, primary, Berman, Abigail T., primary, Ciunci, Christine A., primary, Singh, Aditi P., primary, Wasser, Jeffrey S., primary, Bauml, Joshua M., primary, Langer, Corey J., primary, Cohen, Roger B., primary, and Carpenter, Erica L., primary

Published
2023
Full Text
View/download PDF

29. Supplemental Table 7 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Author

Thompson, Jeffrey C., primary, Yee, Stephanie S., primary, Troxel, Andrea B., primary, Savitch, Samantha L., primary, Fan, Ryan, primary, Balli, David, primary, Lieberman, David B., primary, Morrissette, Jennifer D., primary, Evans, Tracey L., primary, Bauml, Joshua, primary, Aggarwal, Charu, primary, Kosteva, John A., primary, Alley, Evan, primary, Ciunci, Christine, primary, Cohen, Roger B., primary, Bagley, Stephen, primary, Stonehouse-Lee, Susan, primary, Sherry, Victoria E., primary, Gilbert, Elizabeth, primary, Langer, Corey, primary, Vachani, Anil, primary, and Carpenter, Erica L., primary

Published
2023
Full Text
View/download PDF

30. Supplemental Figure 1 from Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer

Author

Aggarwal, Charu, primary, Thompson, Jeffrey C., primary, Chien, Austin L., primary, Quinn, Katie J., primary, Hwang, Wei-Ting, primary, Black, Taylor A., primary, Yee, Stephanie S., primary, Christensen, Theresa E., primary, LaRiviere, Michael J., primary, Silva, Benjamin A., primary, Banks, Kimberly C., primary, Nagy, Rebecca J., primary, Helman, Elena, primary, Berman, Abigail T., primary, Ciunci, Christine A., primary, Singh, Aditi P., primary, Wasser, Jeffrey S., primary, Bauml, Joshua M., primary, Langer, Corey J., primary, Cohen, Roger B., primary, and Carpenter, Erica L., primary

Published
2023
Full Text
View/download PDF

31. Supplemental Figure 1 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Author

Thompson, Jeffrey C., primary, Yee, Stephanie S., primary, Troxel, Andrea B., primary, Savitch, Samantha L., primary, Fan, Ryan, primary, Balli, David, primary, Lieberman, David B., primary, Morrissette, Jennifer D., primary, Evans, Tracey L., primary, Bauml, Joshua, primary, Aggarwal, Charu, primary, Kosteva, John A., primary, Alley, Evan, primary, Ciunci, Christine, primary, Cohen, Roger B., primary, Bagley, Stephen, primary, Stonehouse-Lee, Susan, primary, Sherry, Victoria E., primary, Gilbert, Elizabeth, primary, Langer, Corey, primary, Vachani, Anil, primary, and Carpenter, Erica L., primary

Published
2023
Full Text
View/download PDF

32. Supplemental Figure 3 from Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer

Author

Aggarwal, Charu, primary, Thompson, Jeffrey C., primary, Chien, Austin L., primary, Quinn, Katie J., primary, Hwang, Wei-Ting, primary, Black, Taylor A., primary, Yee, Stephanie S., primary, Christensen, Theresa E., primary, LaRiviere, Michael J., primary, Silva, Benjamin A., primary, Banks, Kimberly C., primary, Nagy, Rebecca J., primary, Helman, Elena, primary, Berman, Abigail T., primary, Ciunci, Christine A., primary, Singh, Aditi P., primary, Wasser, Jeffrey S., primary, Bauml, Joshua M., primary, Langer, Corey J., primary, Cohen, Roger B., primary, and Carpenter, Erica L., primary

Published
2023
Full Text
View/download PDF

33. Supplemental Table 1 from Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer

Author

Aggarwal, Charu, primary, Thompson, Jeffrey C., primary, Chien, Austin L., primary, Quinn, Katie J., primary, Hwang, Wei-Ting, primary, Black, Taylor A., primary, Yee, Stephanie S., primary, Christensen, Theresa E., primary, LaRiviere, Michael J., primary, Silva, Benjamin A., primary, Banks, Kimberly C., primary, Nagy, Rebecca J., primary, Helman, Elena, primary, Berman, Abigail T., primary, Ciunci, Christine A., primary, Singh, Aditi P., primary, Wasser, Jeffrey S., primary, Bauml, Joshua M., primary, Langer, Corey J., primary, Cohen, Roger B., primary, and Carpenter, Erica L., primary

Published
2023
Full Text
View/download PDF

34. Supplemental Table 5 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Author

Thompson, Jeffrey C., primary, Yee, Stephanie S., primary, Troxel, Andrea B., primary, Savitch, Samantha L., primary, Fan, Ryan, primary, Balli, David, primary, Lieberman, David B., primary, Morrissette, Jennifer D., primary, Evans, Tracey L., primary, Bauml, Joshua, primary, Aggarwal, Charu, primary, Kosteva, John A., primary, Alley, Evan, primary, Ciunci, Christine, primary, Cohen, Roger B., primary, Bagley, Stephen, primary, Stonehouse-Lee, Susan, primary, Sherry, Victoria E., primary, Gilbert, Elizabeth, primary, Langer, Corey, primary, Vachani, Anil, primary, and Carpenter, Erica L., primary

Published
2023
Full Text
View/download PDF

35. Supplemental Table 4 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Author

Thompson, Jeffrey C., primary, Yee, Stephanie S., primary, Troxel, Andrea B., primary, Savitch, Samantha L., primary, Fan, Ryan, primary, Balli, David, primary, Lieberman, David B., primary, Morrissette, Jennifer D., primary, Evans, Tracey L., primary, Bauml, Joshua, primary, Aggarwal, Charu, primary, Kosteva, John A., primary, Alley, Evan, primary, Ciunci, Christine, primary, Cohen, Roger B., primary, Bagley, Stephen, primary, Stonehouse-Lee, Susan, primary, Sherry, Victoria E., primary, Gilbert, Elizabeth, primary, Langer, Corey, primary, Vachani, Anil, primary, and Carpenter, Erica L., primary

Published
2023
Full Text
View/download PDF

37. Improving comprehensive genotyping in patients with newly diagnosed non-squamous NSCLC: Results from a prospective trial of a behavioral nudge intervention.

Author

Aggarwal, Charu, primary, Carpenter, Erica L., additional, Scholes, Dylan G., additional, Hwang, Wei-Ting, additional, McWilliams, Tara, additional, Singh, Aditi Puri, additional, Sun, Lova, additional, Kosteva, John A., additional, Costello, Michael Robert, additional, Doucette, Abigail, additional, Gabriel, Peter Edward, additional, Roy, Megan, additional, Martella, Anthony O., additional, Thompson, Jeffrey C., additional, Cohen, Roger B., additional, Langer, Corey J., additional, Shulman, Lawrence N., additional, and Marmarelis, Melina Elpi, additional

Published
2022
Full Text
View/download PDF

38. Transcriptional profiling of single tumour cells from pleural effusions reveals heterogeneity of epithelial to mesenchymal transition and extra‐cellular matrix marker expression

Author

Sen, Moen, primary, Hausler, Ryan M., additional, Dulmage, Keely, additional, Black, Taylor A., additional, Murphy, William, additional, Pletcher Jr, Charles H., additional, Wang, Ling, additional, Chen, Chang, additional, Yee, Stephanie S., additional, Bornheimer, Scott J., additional, Maxwell, Kara N., additional, Stanger, Ben Z., additional, Moore, Jonni S., additional, Thompson, Jeffrey C., additional, and Carpenter, Erica L., additional

Published
2022
Full Text
View/download PDF

39. Association of comprehensive molecular genotyping and overall survival in patients with advanced non-squamous non-small cell lung cancer.

Author

Aggarwal, Charu, primary, Marmarelis, Melina Elpi, additional, Hwang, Wei-Ting, additional, Scholes, Dylan G., additional, McWilliams, Tara, additional, Singh, Aditi Puri, additional, Sun, Lova, additional, Kosteva, John A., additional, Costello, Michael Robert, additional, Cohen, Roger B., additional, Langer, Corey J., additional, Gabriel, Peter Edward, additional, Shulman, Lawrence N., additional, Thompson, Jeffrey C., additional, and Carpenter, Erica L., additional

Published
2022
Full Text
View/download PDF

40. Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC—Results From a Prospective Pilot Study

Author

Thompson, Jeffrey C., primary, Aggarwal, Charu, additional, Wong, Janeline, additional, Nimgaonkar, Vivek, additional, Hwang, Wei-Ting, additional, Andronov, Michelle, additional, Dibardino, David M., additional, Hutchinson, Christoph T., additional, Ma, Kevin C., additional, Lanfranco, Anthony, additional, Moon, Edmund, additional, Haas, Andrew R., additional, Singh, Aditi P., additional, Ciunci, Christine A., additional, Marmarelis, Melina, additional, D’Avella, Christopher, additional, Cohen, Justine V., additional, Bauml, Joshua M., additional, Cohen, Roger B., additional, Langer, Corey J., additional, Vachani, Anil, additional, and Carpenter, Erica L., additional

Published
2022
Full Text
View/download PDF

42. A radiomics-based model for the outcome prediction in COVID-19 positive patients through deep learning with both longitudinal chest x-ray and chest computed tomography images

Author

Iftekharuddin, Khan M., Chen, Weijie, Zou, Chunrui, Mankowski, Walter, Pantalone, Lauren, Setia Verma, Shefali, Mortani Barbosa, Eduardo J., Cook, Tessa S., Noel, Peter B., Carpenter, Erica L., Thompson, Jeffrey C., Shinohara, Russell T., Katz, Sharyn I., and Kontos, Despina

Published
2023
Full Text
View/download PDF

43. Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed Tomography

Author

Hershman, Michelle, primary, Yousefi, Bardia, additional, Serletti, Lacey, additional, Galperin-Aizenberg, Maya, additional, Roshkovan, Leonid, additional, Luna, José Marcio, additional, Thompson, Jeffrey C., additional, Aggarwal, Charu, additional, Carpenter, Erica L., additional, Kontos, Despina, additional, and Katz, Sharyn I., additional

Published
2021
Full Text
View/download PDF

45. Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular Analysis

Author

Till, Jacob E., primary, Black, Taylor A., additional, Gentile, Caren, additional, Abdalla, Aseel, additional, Wang, Zhuoyang, additional, Sangha, Hareena K., additional, Roth, Jacquelyn J., additional, Sussman, Robyn, additional, Yee, Stephanie S., additional, O'Hara, Mark H., additional, Thompson, Jeffrey C., additional, Aggarwal, Charu, additional, Hwang, Wei-Ting, additional, Elenitoba-Johnson, Kojo S.J., additional, and Carpenter, Erica L., additional

Published
2021
Full Text
View/download PDF

46. Incorporation of plasma-based next-generation sequencing to improve guideline-concordant molecular testing in patients with newly diagnosed metastatic nonsquamous non-small cell lung cancer.

Author

Aggarwal, Charu, primary, Marmarelis, Melina Elpi, additional, Hwang, Wei-Ting, additional, Scholes, Dylan G., additional, Singh, Aditi Puri, additional, Bauml, Joshua, additional, Cohen, Roger B., additional, Langer, Corey J., additional, Gabriel, Peter Edward, additional, Shulman, Lawrence N., additional, Thompson, Jeffrey C., additional, Berman, Abigail T., additional, and Carpenter, Erica L., additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results